Member Info for beinthelead

Just checked - I haven’t been rude this morning. Or at least wasn’t trying. Take care gadgie.

Wow. Thanks.

Why?

S protein issues are a red herring.

There’s little point in theorising, using metaphors or providing anecdotal evidence. WE HAVE THE DATA. Our test that detects the spike was perfect with delta. Most others that detected the N didn’t. Today is further evidence.

They’re all out this morning. It’s impressive how many ‘new’ investors this share attracts. The bin is bursting.

Now starting your own threads to bash. Give it up.

Catch up Wall-E. the filter list has a few new names this morning.

Short term memories here. We had a perfect record with Delta. Others, namely FlowFlex etc could not accurately detect it. Innova couldn’t.

This should put the N vs S debate to bed. In fact, go one better and highlight that selecting the S protein offers superior test performance! I believe Vatic will come out with stronger marketing to this regard.

Fantastic news for the platform.

They’re out in force today…

Is this the first time they have referred to Medusa 19 HEALTHCARE?

Hook line and sinker. Not often live data like this gets left on the board.

Thanks.

So… where were you? Rather than play ‘guess who?’, just say where you were.

My expectation based on historic timelines issued by the company and Affy updates to date.

Ok;

Why can’t you say where you were? Who/how would this be traced.

If they are AffiDX, then they are known and the info is not commercially sensitive.

Why can’t you post the photo?

If you were holding for 18 months like a lot of us, I for one would be hiding out til the room was clear, then have a rummage. Job or no job :).

Gadgie, with respect, you have a habit of posting aged info that is either dead in the water, or a long standing partnership that is years away from bearing fruit.

Suggest reviewing the September BU for Affy info.

Another ‘just nearly’ story for the almanac.

Let’s get those Affimers turning over a few quid and disrupting the current LFT market before we run away on therapeutics…

Thanks Muck. Appears their view is similar to that quoted by Vatic.

Must admit, I missed that alias. Good spot R.